Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
Glenmark Pharmaceuticals (GNP IN)
Watchlist
140
Analysis
Health Care
•
India
Glenmark Pharmaceuticals Ltd., is a pharmaceutical company. The Company develops generic drugs for inflammation, metabolic disorders, and pain.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
361 Degrees International
•
02 Jul 2019 00:00
Asia HY Monthly - Vulnerability Of Asian Credit Market To External Shocks (2019) - Lucror Analytics
In this month’s “In-Focus” section, we discuss the vulnerability of Asian credits to external shocks, with the threat this year being the...
Lucror Analytics
Follow
66 Views
Share
bullish
•
361 Degrees International
•
26 Jun 2019 00:00
Asia HY Trade Recommendations - June 2019 - Lucror Analytics
The Asia HY Trade Recommendations report for June includes a summary of our recommendations, as well as our high-conviction ideas. We also...
Lucror Analytics
Follow
64 Views
Share
bullish
•
361 Degrees International
•
04 Jun 2019 00:00
Asia HY Monthly - LARA And Credit Bias Study - Lucror Analytics
In this month’s “In-Focus” section, we discuss LARA and Credit Bias developments over the past few years for companies under our coverage,...
Lucror Analytics
Follow
72 Views
Share
bullish
•
Fosun International
•
30 May 2019 00:00
Lucror Analytics - Morning Views Asia - 30 May 2019
Lucror Analytics Morning Views comprise our fundamental credit analysis, opinions and trade recommendations on high yield issuers in the region,...
Lucror Analytics
Follow
64 Views
Share
bullish
•
Glenmark Pharmaceuticals
•
30 May 2019 00:00
Glenmark - Earnings Flash - FY 2018-19 Results - Lucror Analytics
Glenmark's Q4 and FY 2018-19 results were positive. The momentum in revenue growth was sustained in the final quarter (following a surprisingly...
Lucror Analytics
Follow
75 Views
Share
First
Previous
20
21
22
23
24
25
26
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.40.5
x